Plaque rupture in humans and mice

被引:200
|
作者
Schwartz, Stephen M.
Galis, Zorina S.
Rosenfeld, Michael E.
Falk, Erling
机构
[1] Univ Washington, Dept Pathol, Seattle, WA 98109 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Lilly Res Labs, Indianapolis, IN USA
[4] Univ Aarhus, Dept Cardiol, DK-8000 Aarhus C, Denmark
关键词
plaque rupture; murine atherosclerosis; fibrous cap; vulnerable plaque; progression;
D O I
10.1161/01.ATV.0000261709.34878.20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite the many studies of murine atherosclerosis, we do not yet know the relevance of the natural history of this model to the final events precipitated by plaque disruption of human atherosclerotic lesions. The literature has become particularly confused because of the common use of terms such as "instability", "vulnerable", "rupture", or even "thrombosis" for features of plaques in murine model systems not yet shown to rupture spontaneously and in an animal surprisingly resistant to formation of thrombi at sites of atherosclerosis. We suggest that use of conclusory terms like "vulnerable" and "stable" should be discouraged. Similarly, terms such as "buried fibrous caps" that imply preceding events that are unproven tend to create confusion. We will argue that such terminology may mislead readers by implying knowledge that does not yet exist. We suggest, instead, a focus on specific processes that various forms of data have implicated in plaque progression. For example, formation of the fibrous cap, protease activation, and cell death in the necrotic core can be well described and have all been modeled in well-defined experiments. The relevance of such well-defined, objective, descriptive observations in the mouse can be tested for relevance against data from human pathology.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [1] Biochemical markers of coronary plaque rupture in humans
    Marraccini, P
    Lucbrano, W
    Bamoshmoosh, M
    Testa, R
    Battaglia, D
    Papa, A
    Mazzarisi, A
    Cocci, F
    EUROPEAN HEART JOURNAL, 2004, 25 : 232 - 233
  • [2] A novel plaque rupture model in mice
    De Meyer, Guido R. Y.
    Van der Donckt, Carole
    Van Herck, Jozef
    Vanhoutte, Greetje
    Martinet, Wim
    Schrijvers, Dorien
    Verhoye, Marleen
    Van Der Linden, Annemie
    Bult, Hidde
    Herman, Arnold G.
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 313 - 313
  • [3] Serial changes in coronary dimensions in acute thrombosis in humans: Plaque rupture and erosion
    Farb, A
    Carter, AJ
    Burke, AP
    Liang, YH
    Smialek, J
    Virmani, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7602 - 7602
  • [4] Plaque rupture
    Lee, R
    SECOND US-JAPANESE DIALOGUE ON LIPID DISORDERS AND CORONARY ARTERY DISEASE, 2000, 243 : 21 - 25
  • [5] Preventing plaque rupture
    Alexandra Flemming
    Nature Reviews Drug Discovery, 2008, 7 : 891 - 891
  • [6] Carotid plaque rupture
    Keenan, Niall G.
    Sheppard, Mary N.
    Nott, David M.
    Pennell, Dudley J.
    Mohiaddin, Raad H.
    LANCET, 2009, 374 (9702): : 1703 - 1703
  • [7] The effect of clopidogrel on atherosclerotic plaque progression and rupture in apolipoprotein E knockout mice
    Williams, H
    Baker, N
    Poole, A
    Jackson, CL
    ATHEROSCLEROSIS, 2005, 181 (01) : S6 - S6
  • [8] A simple method of plaque rupture induction in apolipoprotein E-deficient mice
    Sasaki, Takeshi
    Kuzuya, Masafumi
    Nakamura, Kae
    Cheng, Xian Wu
    Shibata, Tami
    Sato, Kohji
    Iguchi, Akihisa
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) : 1304 - 1309
  • [9] Thrombin inhibition with melagatran prevents plaque rupture in apolipoprotein E knockout mice
    Karanam, S
    Fritsche-Danielson, R
    Jackson, CL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E76 - E77
  • [10] Thrombin inhibition with melegotran prevents plaque rupture in apolipoprotein E knockout mice
    Karanam, S
    Danielson, RF
    Jackson, C
    HEART, 2005, 91 (07)